MDS Nordion says Russia deal to supply key isotope

TORONTO, Sept 27 (Reuters) - A deal with Russia's Rosatom is expected to provide MDS Nordion with a key medical isotope for at least the next 10 years, but the move is not intended as a permanent replacement for supplies from an aging Canadian reactor, the company said on Monday.